• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上海奥密克戎变异株流行期间老年人发生严重 COVID-19 结局的老年风险和保护因素。

Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave.

机构信息

Department of Infectious Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.

出版信息

Emerg Microbes Infect. 2022 Dec;11(1):2045-2054. doi: 10.1080/22221751.2022.2109517.

DOI:10.1080/22221751.2022.2109517
PMID:35924388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9448390/
Abstract

Shanghai has been experiencing the Omicron wave since March 2022. Though several studies have evaluated the risk factors of severe infections, the analyses of BA.2 infection risk and protective factors among geriatric people were much limited. This multicentre cohort study described clinical characteristics, and assessed risk and protective factors for geriatric Omicron severe infections. A total of 1377 patients older than 60 were enrolled, with 75.96% having comorbidities. The median viral shedding time and hospitalization time were nine and eight days, respectively. Severe and critical were associated with longer virus clearance time (aOR [95%CI]:0.706 (0.533-0.935),  = .015), while fully vaccinated/booster and paxlovid use shortened viral shedding time (1.229 [1.076-1.402],  = .002; 1.140 [0.019-1.274],  = .022, respectively). Older age (>80), cerebrovascular disease, and chronic kidney disease were risk factors of severe/critical. Fully vaccination was a significant protective factor against severe infections (0.237 [0.071-0.793],  = .019). We found patients with more than two comorbidities were more likely to get serious outcomes. These findings demonstrated that in the elderly older than 60 years old, older age (aged over 80), cerebrovascular disease, and chronic kidney disease were risk factors for severe infection. Patients with more than two comorbidities were more likely to get serious outcomes. Fully vaccinated/booster patients were less likely to be severe and vaccinations could shorten viral shedding time. The limitation of lacking an overall spectrum of COVID-19 infections among elders could be compensated in other larger-scale studies in the future.

摘要

上海自 2022 年 3 月以来一直经历着奥密克戎波。尽管有几项研究评估了严重感染的危险因素,但对老年人 BA.2 感染风险和保护因素的分析却非常有限。本多中心队列研究描述了临床特征,并评估了老年奥密克戎重症感染的风险和保护因素。共纳入 1377 名年龄大于 60 岁的患者,其中 75.96%有合并症。中位病毒脱落时间和住院时间分别为 9 天和 8 天。严重和危重症与病毒清除时间延长相关(aOR [95%CI]:0.706 [0.533-0.935],=0.015),而完全接种/加强接种和使用帕罗韦德缩短了病毒脱落时间(1.229 [1.076-1.402],=0.002;1.140 [0.019-1.274],=0.022)。年龄较大(>80 岁)、脑血管疾病和慢性肾脏病是严重/危重症的危险因素。完全接种是严重感染的显著保护因素(0.237 [0.071-0.793],=0.019)。我们发现合并症超过两种的患者更有可能出现严重结局。这些发现表明,在 60 岁以上的老年人中,年龄较大(>80 岁)、脑血管疾病和慢性肾脏病是严重感染的危险因素。合并症超过两种的患者更有可能出现严重结局。完全接种/加强接种的患者不太可能出现严重感染,且接种疫苗可以缩短病毒脱落时间。未来在其他更大规模的研究中,可以弥补缺乏老年人 COVID-19 感染全貌的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/84c8d351e59b/TEMI_A_2109517_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/5ec7b72d0468/TEMI_A_2109517_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/96fac2cce8a5/TEMI_A_2109517_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/a749e70db07f/TEMI_A_2109517_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/84c8d351e59b/TEMI_A_2109517_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/5ec7b72d0468/TEMI_A_2109517_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/96fac2cce8a5/TEMI_A_2109517_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/a749e70db07f/TEMI_A_2109517_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc1c/9448390/84c8d351e59b/TEMI_A_2109517_F0004_OC.jpg

相似文献

1
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave.上海奥密克戎变异株流行期间老年人发生严重 COVID-19 结局的老年风险和保护因素。
Emerg Microbes Infect. 2022 Dec;11(1):2045-2054. doi: 10.1080/22221751.2022.2109517.
2
Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2.灭活 COVID-19 疫苗加强针缩短了感染奥密克戎变异株 BA.2 患者的病毒脱落时间。
Int J Infect Dis. 2023 Jun;131:26-31. doi: 10.1016/j.ijid.2023.03.028. Epub 2023 Mar 21.
3
Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort study.确定 CKD、卧床病史和癌症等更高危合并症,并分析其对住院奥密克戎患者预后的影响:一项多中心队列研究。
Emerg Microbes Infect. 2022 Dec;11(1):2501-2509. doi: 10.1080/22221751.2022.2122581.
4
Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.中国广东奥密克戎 BA.2 感染突破性感染用灭活 COVID-19 疫苗加强接种的效果:一项队列研究。
Front Immunol. 2023 Oct 17;14:1257360. doi: 10.3389/fimmu.2023.1257360. eCollection 2023.
5
Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China.中国深圳 SARS-CoV-2 奥密克戎 BA.2 变异株传播特性和灭活疫苗对传播的有效性。
Front Immunol. 2024 Jan 8;14:1290279. doi: 10.3389/fimmu.2023.1290279. eCollection 2023.
6
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.奥密克戎 BA.5 感染的灭活 COVID-19 疫苗加强针效力:成人密切接触者的匹配队列研究。
Respir Res. 2023 Oct 12;24(1):246. doi: 10.1186/s12931-023-02542-y.
7
A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株德尔塔迅速被奥密克戎取代:新冠病毒疾病病例数出现前所未有的激增,住院人数减少,上呼吸道病毒载量相当。
medRxiv. 2022 Jan 28:2022.01.26.22269927. doi: 10.1101/2022.01.26.22269927.
8
Risk factors for progression to severe infection and prolonged viral clearance time in hospitalized elderly patients infected with the Omicron variant of SARS-CoV-2: a retrospective study at Shanghai Fourth People's Hospital, School of Medicine, Tongji University.感染新冠病毒奥密克戎变异株的住院老年患者进展为严重感染及病毒清除时间延长的危险因素:同济大学医学院附属上海市第四人民医院的一项回顾性研究
Front Microbiol. 2024 Apr 15;15:1361197. doi: 10.3389/fmicb.2024.1361197. eCollection 2024.
9
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.2022年2月至6月上海市奥密克戎BA.2毒株所致新冠病毒病的疾病负担及临床严重程度评估
medRxiv. 2022 Jul 12:2022.07.11.22277504. doi: 10.1101/2022.07.11.22277504.
10
Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.上海一项多中心、回顾性、观察性研究显示,合并症使感染 SARS-CoV-2 奥密克戎变异株的患者病毒脱落时间延长。
J Infect Public Health. 2023 Feb;16(2):182-189. doi: 10.1016/j.jiph.2022.12.003. Epub 2022 Dec 6.

引用本文的文献

1
Impact of Vaccination and Public Health Measures on the Severity of SARS-CoV-2 Omicron Infections in China: A Systematic Review and Meta-Regression Analysis.疫苗接种和公共卫生措施对中国新冠病毒奥密克戎感染严重程度的影响:一项系统评价和Meta回归分析
Vaccines (Basel). 2025 Jul 12;13(7):747. doi: 10.3390/vaccines13070747.
2
Long-term Cardiovascular Outcomes in Patients with Omicron COVID-19 and Elevated Cardiac Biomarkers: A Prospective Multicenter Cohort Study in Shanghai, China.奥密克戎新冠病毒感染合并心脏生物标志物升高患者的长期心血管结局:中国上海的一项前瞻性多中心队列研究
Int J Med Sci. 2025 Jun 9;22(12):2884-2895. doi: 10.7150/ijms.112282. eCollection 2025.
3

本文引用的文献

1
The Johns Hopkins University Center for Systems Science and Engineering COVID-19 Dashboard: data collection process, challenges faced, and lessons learned.约翰斯·霍普金斯大学系统科学与工程中心 COVID-19 数据仪表盘:数据收集流程、面临的挑战和经验教训。
Lancet Infect Dis. 2022 Dec;22(12):e370-e376. doi: 10.1016/S1473-3099(22)00434-0. Epub 2022 Aug 31.
2
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages.SARS-CoV-2 奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 亚谱系的抗体逃逸。
Cell Host Microbe. 2022 Aug 10;30(8):1077-1083.e4. doi: 10.1016/j.chom.2022.05.001. Epub 2022 May 8.
3
Viral sepsis-induced mortality of older patients infected by the Omicron subvariant BA.5 of SARS-CoV-2: a retrospective study.
新型冠状病毒Omicron变异株BA.5感染导致老年患者的病毒败血症死亡率:一项回顾性研究。
BMC Infect Dis. 2025 Apr 22;25(1):577. doi: 10.1186/s12879-025-10894-7.
4
Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases.熊去氧胆酸可缓解慢性肝病患者新冠病毒病的临床严重程度。
Front Med (Lausanne). 2025 Feb 6;12:1494248. doi: 10.3389/fmed.2025.1494248. eCollection 2025.
5
Reduced SARS-CoV-2 Infection Rates in Lab Workers Conducting Nucleic Acid Testing: Controlling for the Healthy Worker Effect.从事核酸检测的实验室工作人员中新冠病毒感染率降低:对健康工人效应的控制
J Epidemiol Glob Health. 2025 Jan 29;15(1):10. doi: 10.1007/s44197-025-00343-8.
6
Consequences of COVID-19 for geriatric patients during a pandemic.新冠疫情期间COVID-19对老年患者的影响。
Sci Rep. 2025 Jan 24;15(1):3136. doi: 10.1038/s41598-024-84379-z.
7
Temporal, spatial and demographic distributions characteristics of COVID-19 symptom clusters from chinese medicine perspective: a systematic cross-sectional study in China from 2019 to 2023.从中医角度看新型冠状病毒肺炎症状群的时间、空间和人口统计学分布特征:一项2019年至2023年在中国开展的系统性横断面研究
Chin Med. 2024 Dec 18;19(1):171. doi: 10.1186/s13020-024-01043-4.
8
Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge.奥密克戎毒株流行期间接受阿兹夫定治疗的新冠患者的免疫表型特征及临床结局
Front Immunol. 2024 Nov 25;15:1465238. doi: 10.3389/fimmu.2024.1465238. eCollection 2024.
9
Factors influencing COVID-19 vaccination intentions and mediating effects among older adults in Southwest China.影响中国西南部老年人 COVID-19 疫苗接种意愿的因素及中介效应。
Sci Rep. 2024 Nov 1;14(1):26357. doi: 10.1038/s41598-024-76437-3.
10
Liver function abnormality on admission predicts long COVID syndrome in digestive system.入院时肝功能异常可预测消化系统的长期新冠综合征。
Heliyon. 2024 Sep 12;10(19):e37664. doi: 10.1016/j.heliyon.2024.e37664. eCollection 2024 Oct 15.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
SARS-CoV-2 奥密克戎 BA.2 刺突的病毒学特征。
Cell. 2022 Jun 9;185(12):2103-2115.e19. doi: 10.1016/j.cell.2022.04.035. Epub 2022 May 2.
4
Association of COVID-19 Vaccination With Risk of COVID-19 Infection, Hospitalization, and Death in Heart Transplant Recipients.COVID-19 疫苗接种与心脏移植受者 COVID-19 感染、住院和死亡风险的关联。
JAMA Cardiol. 2022 Jun 1;7(6):651-654. doi: 10.1001/jamacardio.2022.0670.
5
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
6
COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.2022年1月6日至2022年3月21日中国香港特别行政区的新冠病毒病死亡率及疫苗接种率
China CDC Wkly. 2022 Apr 8;4(14):288-292. doi: 10.46234/ccdcw2022.071.
7
COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.2022 年 1 月 6 日至 2022 年 3 月 21 日,中国香港特别行政区的 COVID-19 死亡率和疫苗接种率。
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):545-548. doi: 10.15585/mmwr.mm7115e1.
8
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.未接种疫苗和接种疫苗的个体中感染原始、Delta 或奥密克戎 SARS-CoV-2 的传染性病毒载量。
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
9
Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022.从2022年初香港第五波新冠疫情中吸取的教训。
Emerg Microbes Infect. 2022 Dec;11(1):1072-1078. doi: 10.1080/22221751.2022.2060137.
10
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.SARS-CoV-2 奥密克戎亚谱系的抗体逃逸特性。
Nature. 2022 Apr;604(7906):553-556. doi: 10.1038/s41586-022-04594-4. Epub 2022 Mar 3.